RS56690B1 - Derivati trisaharida, i njihova upotreba kao adjuvanasa - Google Patents

Derivati trisaharida, i njihova upotreba kao adjuvanasa

Info

Publication number
RS56690B1
RS56690B1 RS20171307A RSP20171307A RS56690B1 RS 56690 B1 RS56690 B1 RS 56690B1 RS 20171307 A RS20171307 A RS 20171307A RS P20171307 A RSP20171307 A RS P20171307A RS 56690 B1 RS56690 B1 RS 56690B1
Authority
RS
Serbia
Prior art keywords
trisaccharide
fatty acid
substituted
acid ester
groups
Prior art date
Application number
RS20171307A
Other languages
English (en)
Serbian (sr)
Inventor
Bree Johannes Gernardus Mathias Marie Van
Everardus Joannes Peter Maria Schenkelaars
Jouwert Anne Turkstra
Maria Aldegonda Jacoba Kriek
Robert Patrick Hof
Wilhelmus Martinus Maria Schaaper
Original Assignee
Immunovo B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo B V filed Critical Immunovo B V
Publication of RS56690B1 publication Critical patent/RS56690B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
RS20171307A 2010-06-11 2011-06-03 Derivati trisaharida, i njihova upotreba kao adjuvanasa RS56690B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
EP11725217.1A EP2580226B1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (1)

Publication Number Publication Date
RS56690B1 true RS56690B1 (sr) 2018-03-30

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20171307A RS56690B1 (sr) 2010-06-11 2011-06-03 Derivati trisaharida, i njihova upotreba kao adjuvanasa

Country Status (25)

Country Link
US (2) US9327020B2 (enExample)
EP (3) EP2397484A1 (enExample)
JP (2) JP6004586B2 (enExample)
KR (1) KR101929973B1 (enExample)
CN (1) CN103154013B (enExample)
AU (1) AU2011262606B2 (enExample)
BR (1) BR112012031440A2 (enExample)
CA (1) CA2802023C (enExample)
CY (1) CY1119704T1 (enExample)
DK (1) DK2580226T3 (enExample)
ES (1) ES2654156T3 (enExample)
HR (1) HRP20171947T1 (enExample)
HU (1) HUE035187T2 (enExample)
IL (1) IL223570A (enExample)
LT (1) LT2580226T (enExample)
MX (1) MX342946B (enExample)
NO (1) NO2580226T3 (enExample)
PL (1) PL2580226T3 (enExample)
PT (1) PT2580226T (enExample)
RS (1) RS56690B1 (enExample)
RU (1) RU2595717C2 (enExample)
SI (1) SI2580226T1 (enExample)
SM (1) SMT201700603T1 (enExample)
WO (1) WO2011155822A1 (enExample)
ZA (1) ZA201209395B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
NZ728551A (en) * 2014-07-24 2023-02-24 Litevax B V Sulphated carbohydrate fatty acid esters as vaccine adjuvants
KR102922337B1 (ko) 2023-10-11 2026-02-05 세종대학교산학협력단 삼당류의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
ATE252373T1 (de) * 1994-08-04 2003-11-15 Elan Drug Delivery Ltd Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
DE602005010101D1 (de) * 2005-12-01 2008-11-13 Wella Ag Verwendung von Di- oder Oligosaccharidepolyestern in Haarstylingprodukten
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
US8993536B2 (en) * 2009-02-02 2015-03-31 Otsuka Chemical Co., Ltd. Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
IL223570A (en) 2017-03-30
JP2016216471A (ja) 2016-12-22
MX342946B (es) 2016-10-18
JP6004586B2 (ja) 2016-10-12
DK2580226T3 (en) 2018-01-08
CA2802023C (en) 2020-07-14
CA2802023A1 (en) 2011-12-15
RU2013100945A (ru) 2014-07-20
BR112012031440A2 (pt) 2017-04-18
SMT201700603T1 (it) 2018-03-08
EP2580226B1 (en) 2017-11-29
HRP20171947T1 (hr) 2018-02-23
NO2580226T3 (enExample) 2018-04-28
US20130273082A1 (en) 2013-10-17
MX2012014422A (es) 2013-08-27
LT2580226T (lt) 2018-02-26
HUE035187T2 (hu) 2018-05-02
WO2011155822A1 (en) 2011-12-15
PL2580226T3 (pl) 2018-05-30
US20170057987A1 (en) 2017-03-02
EP2580226A1 (en) 2013-04-17
KR20130056273A (ko) 2013-05-29
JP2013528211A (ja) 2013-07-08
EP3312188A1 (en) 2018-04-25
ES2654156T3 (es) 2018-02-12
AU2011262606B2 (en) 2016-10-27
CY1119704T1 (el) 2018-06-27
US9327020B2 (en) 2016-05-03
CN103154013A (zh) 2013-06-12
EP2397484A1 (en) 2011-12-21
AU2011262606A1 (en) 2013-01-10
SI2580226T1 (en) 2018-04-30
KR101929973B1 (ko) 2018-12-18
ZA201209395B (en) 2014-05-28
RU2595717C2 (ru) 2016-08-27
CN103154013B (zh) 2017-03-15
PT2580226T (pt) 2018-01-05

Similar Documents

Publication Publication Date Title
US8637659B2 (en) Mono-and disaccharide derivatives
EP1194166B1 (en) Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
JP2003502388A5 (enExample)
PT988862E (pt) Formulação compreendendo um antigénio, um adjuvante indutor de th-1 e um aminoácido pouco solúvel em água, para utilização em imunização
US20170057987A1 (en) Trisaccharide Derivates, and Their Use as Adjuvants
US20230102247A1 (en) Methods and compositions relating to ionic liquid adjuvants
AU2015294769B2 (en) Adjuvants
CA2954043C (en) Carbohydrate ester adjuvants